204 related articles for article (PubMed ID: 37353480)
1. Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis.
Liu X; Bai F; Wang Y; Wang C; Chan HL; Zheng C; Fang J; Zhu WG; Pei XH
Cell Death Dis; 2023 Jun; 14(6):370. PubMed ID: 37353480
[TBL] [Abstract][Full Text] [Related]
2. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.
Bai F; Zhang LH; Liu X; Wang C; Zheng C; Sun J; Li M; Zhu WG; Pei XH
Theranostics; 2021; 11(17):8218-8233. PubMed ID: 34373738
[No Abstract] [Full Text] [Related]
3. GATA3 functions downstream of BRCA1 to promote DNA damage repair and suppress dedifferentiation in breast cancer.
Wang X; Bai F; Liu X; Peng B; Xu X; Zhang H; Fu L; Zhu WG; Wang B; Pei XH
BMC Biol; 2024 Apr; 22(1):85. PubMed ID: 38627785
[TBL] [Abstract][Full Text] [Related]
4. Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway.
Bai F; Wang C; Liu X; Hollern D; Liu S; Fan C; Liu C; Ren S; Herschkowitz JI; Zhu WG; Pei XH
Cell Death Dis; 2022 Mar; 13(3):195. PubMed ID: 35236825
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
[TBL] [Abstract][Full Text] [Related]
6. Loss of function of GATA3 induces basal-like mammary tumors.
Bai F; Zheng C; Liu X; Chan HL; Liu S; Ma J; Ren S; Zhu WG; Pei XH
Theranostics; 2022; 12(2):720-733. PubMed ID: 34976209
[No Abstract] [Full Text] [Related]
7. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.
Tam WL; Lu H; Buikhuisen J; Soh BS; Lim E; Reinhardt F; Wu ZJ; Krall JA; Bierie B; Guo W; Chen X; Liu XS; Brown M; Lim B; Weinberg RA
Cancer Cell; 2013 Sep; 24(3):347-64. PubMed ID: 24029232
[TBL] [Abstract][Full Text] [Related]
10. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
[TBL] [Abstract][Full Text] [Related]
11. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.
Ma J; Liu C; Yang D; Song J; Zhang J; Wang T; Wang M; Xu W; Li X; Ding S; Zhan J; Zhang H
Sci China Life Sci; 2019 Sep; 62(9):1229-1242. PubMed ID: 31376015
[TBL] [Abstract][Full Text] [Related]
12. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
Zhang L; Liu H; Mu X; Cui J; Peng Z
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
[TBL] [Abstract][Full Text] [Related]
14. Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis.
Sobolev VV; Khashukoeva AZ; Evina OE; Geppe NA; Chebysheva SN; Korsunskaya IM; Tchepourina E; Mezentsev A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163444
[TBL] [Abstract][Full Text] [Related]
15. Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß.
Chu IM; Lai WC; Aprelikova O; El Touny LH; Kouros-Mehr H; Green JE
PLoS One; 2013; 8(4):e61125. PubMed ID: 23577196
[TBL] [Abstract][Full Text] [Related]
16. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.
Yu W; Huang W; Yang Y; Qiu R; Zeng Y; Hou Y; Sun G; Shi H; Leng S; Feng D; Chen Y; Wang S; Teng X; Yu H; Wang Y
Cell Death Dis; 2019 Nov; 10(11):832. PubMed ID: 31685800
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers.
Tkocz D; Crawford NT; Buckley NE; Berry FB; Kennedy RD; Gorski JJ; Harkin DP; Mullan PB
Oncogene; 2012 Aug; 31(32):3667-78. PubMed ID: 22120723
[TBL] [Abstract][Full Text] [Related]
18. CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.
Pei XH; Bai F; Smith MD; Usary J; Fan C; Pai SY; Ho IC; Perou CM; Xiong Y
Cancer Cell; 2009 May; 15(5):389-401. PubMed ID: 19411068
[TBL] [Abstract][Full Text] [Related]
19. In situ proximity ligation detection of c-Jun/AP-1 dimers reveals increased levels of c-Jun/Fra1 complexes in aggressive breast cancer cell lines in vitro and in vivo.
Baan B; Pardali E; ten Dijke P; van Dam H
Mol Cell Proteomics; 2010 Sep; 9(9):1982-90. PubMed ID: 20511396
[TBL] [Abstract][Full Text] [Related]
20. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
